Gupta Anindya Kumar, Kumar Amit, Chandrashekhar N
Department of Psychiatry, Command Hospital Air Force, Base Hospital, Delhi, India.
Department of Psychiatry, Command Hospital (AF), Bengaluru, Karnataka, India.
Ind Psychiatry J. 2021 Oct;30(Suppl 1):S93-S96. doi: 10.4103/0972-6748.328795. Epub 2021 Oct 22.
Studies have suggested that repetitive transcranial magnetic stimulation (rTMS) could be efficacious in the treatment of major depression and other psychiatric indications. Alcohol-dependence syndrome is difficult to treat, and the relapse rate is high, even following the standard treatment protocol. No study has been done so far in India for the use of rTMS as an adjuvant therapy in the relapse prevention of patients with alcohol-dependence syndrome. Hence, the current study is an open-label study to explore the same.
The aim of this study was to study the feasibility of rTMS in alcohol-dependence syndrome patients, the side effects if any, and the number of relapses that they may suffer from vis-a-vis patients with standard treatment protocols.
In a prospective, open-label study design, 100 freshly diagnosed cases of alcohol-dependence syndrome were included, and after suitable randomization, half of them were given adjuvant rTMS along with standard treatment and the rest received only standard treatment. The rates of relapse into drinking were compared for both groups. The data were compiled and analyzed with appropriate statistical methods.
Participants given adjuvant rTMS showed significantly less number of relapses into drinking compared to the control group on standard treatment for alcohol-dependence syndrome.
In the present study, though the sample size is small, a significant change with this novel treatment has been found. Whether this change is maintained over a period of time is to be seen by other longitudinal studies.
研究表明,重复经颅磁刺激(rTMS)可能对治疗重度抑郁症及其他精神疾病有效。酒精依赖综合征难以治疗,即便遵循标准治疗方案,复发率仍很高。目前在印度尚未开展关于使用rTMS作为酒精依赖综合征患者预防复发辅助治疗的研究。因此,本研究是一项开放标签研究,旨在探索这一治疗方法。
本研究旨在探讨rTMS用于酒精依赖综合征患者的可行性、可能出现的副作用,以及与接受标准治疗方案的患者相比,rTMS治疗组患者的复发次数。
采用前瞻性、开放标签研究设计,纳入100例新诊断的酒精依赖综合征患者,经适当随机分组后,其中一半患者在接受标准治疗时加用rTMS辅助治疗,其余患者仅接受标准治疗。比较两组患者的饮酒复发率。采用适当的统计方法对数据进行整理和分析。
与接受酒精依赖综合征标准治疗的对照组相比,接受rTMS辅助治疗的患者饮酒复发次数显著减少。
在本研究中,尽管样本量较小,但已发现这种新治疗方法产生了显著变化。这种变化能否在一段时间内持续,有待其他纵向研究进一步观察。